Lombard Odier Asset Management (Switzerland)’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-17,069
| Closed | -$210K | – | 369 |
|
|
2020
Q2 | $210K | Hold |
17,069
| – | – | 0.03% | 131 |
|
|
2020
Q1 | $153K | Hold |
17,069
| – | – | 0.02% | 325 |
|
|
2019
Q4 | $167K | Hold |
17,069
| – | – | 0.02% | 359 |
|
|
2019
Q3 | $117K | Hold |
17,069
| – | – | 0.01% | 348 |
|
|
2019
Q2 | $158K | Hold |
17,069
| – | – | 0.02% | 327 |
|
|
2019
Q1 | $268K | Sell |
17,069
-67,135
| -80% | -$1.05M | 0.03% | 315 |
|
|
2018
Q4 | $1.3M | Buy |
84,204
+44,689
| +113% | +$689K | 0.15% | 113 |
|
|
2018
Q3 | $851K | Sell |
39,515
-6,041
| -13% | -$130K | 0.08% | 192 |
|
|
2018
Q2 | $1.11M | Sell |
45,556
-6,531
| -13% | -$159K | 0.12% | 165 |
|
|
2018
Q1 | $890K | Buy |
+52,087
| New | +$890K | 0.09% | 193 |
|
|
2015
Q3 | – | Sell |
-7,194
| Closed | -$425K | – | 398 |
|
|
2015
Q2 | $425K | Sell |
7,194
-1,881
| -21% | -$111K | 0.03% | 370 |
|
|
2015
Q1 | $570K | Sell |
9,075
-7,938
| -47% | -$499K | 0.06% | 287 |
|
|
2014
Q4 | $978K | Buy |
17,013
+36
| +0.2% | +$2.07K | 0.11% | 149 |
|
|
2014
Q3 | $917K | Buy |
16,977
+10,733
| +172% | +$580K | 0.02% | 553 |
|
|
2014
Q2 | $326K | Buy |
+6,244
| New | +$326K | 0.04% | 289 |
|